APA (7th ed.) Citation

Egorova, A., Selutin, A., Maretina, M., Selkov, S., Baranov, V., & Kiselev, A. (2020, October). Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells. Pharmaceuticals.

Chicago Style (17th ed.) Citation

Egorova, Anna, Alexander Selutin, Marianna Maretina, Sergei Selkov, Vladislav Baranov, and Anton Kiselev. "Characterization of IRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells." Pharmaceuticals Oct. 2020.

MLA (9th ed.) Citation

Egorova, Anna, et al. "Characterization of IRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells." Pharmaceuticals, Oct. 2020.